Immune related adverse events across cancer types: Incidence, risk factors and survival

被引：0
|
作者：
Owen, D. H. [1 ]
Burkart, J. [1 ]
Patel, S. [1 ]
Wei, L. [2 ]
Tinoco, G. [1 ]
Liebner, D. [1 ]
He, K. [1 ]
Shields, P. G. [1 ]
Bertino, E. M. [1 ]
Presley, C. J. [1 ]
Johns, A. [1 ]
Folefac, E. [1 ]
Olencki, T. [1 ]
Carbone, D. P. [1 ]
Verschraegen, C. [1 ]
Otterson, G. A. [1 ]
Kendra, K. L. [1 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Div Med Oncol, James Canc Hosp, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, James Canc Hosp, Columbus, OH 43210 USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1772P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
    Albandar, Heidar J.
    Fuqua, Jacob
    Albandar, Jasim M.
    Safi, Salahuddin
    Merrill, Samuel A.
    Ma, Patrick C.
    CANCERS, 2021, 13 (05) : 1 - 15
  • [42] Testing Immune-Related Adverse Events in Cancer Immunotherapy
    Farmer, Jocelyn R.
    CLINICS IN LABORATORY MEDICINE, 2019, 39 (04) : 669 - +
  • [43] Immune-Related Adverse Events in Patients with Lung Cancer
    Guilherme Sacchi de Camargo Correia
    Tanmayi Pai
    Shenduo Li
    Dana Connor
    Yujie Zhao
    Yanyan Lou
    Rami Manochakian
    Current Oncology Reports, 2023, 25 : 1259 - 1275
  • [44] Immune-Related Adverse Events Due to Cancer Immunotherapy
    Benesova, Karolina
    Leipe, Jan
    AKTUELLE RHEUMATOLOGIE, 2020, 45 (06) : 535 - 543
  • [45] Immune-Related Adverse Events in Patients with Lung Cancer
    Correia, Guilherme Sacchi de Camargo
    Pai, Tanmayi
    Li, Shenduo
    Connor, Dana
    Zhao, Yujie
    Lou, Yanyan
    Manochakian, Rami
    CURRENT ONCOLOGY REPORTS, 2023, 25 (11) : 1259 - 1275
  • [46] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITOR THERAPY ARE ASSOCIATED WITH ENHANCED SURVIVAL AND DISEASE-SPECIFIC INCIDENCE
    Vick, Eric
    Abuali, Inas
    Kelleher, Andrew
    Ludvigsen, Sarah
    Moore, Nathanael
    Arias, Nicholas
    Gulati, Shuchi
    Wise-Draper, Trisha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A152 - A153
  • [47] Immune-Related Adverse Events are Associated with Survival in Chinese Lung Cancer Patients Treated With Immunotherapy
    Zhang, Y.
    Yan, H.
    Zeng, L.
    Zhou, G.
    Wu, Y.
    Qin, H.
    Yang, N.
    Huang, Z.
    Yang, D.
    Zhang, X.
    Zhang, Y.
    Graham-Siegenthaler, K.
    Walls, R.
    Hamzic, S.
    He, Y.
    Mohindra, R.
    Chandler, S.
    Li, Z.
    Luo, R.
    Saha, A.
    Hammer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S270 - S270
  • [48] Cutaneous immune-related adverse events predict longer patient survival in advanced cancer patients
    Lu, C.
    Zhang, S.
    Tang, K.
    Ugwu-Dike, P.
    Raval, N.
    Seo, J.
    Wan, G.
    Nguyen, N.
    Alexander, N.
    Jairath, R.
    Phillipps, J.
    Leung, B.
    Theodosakis, N.
    Zubiri, L.
    Boland, G.
    Liu, D.
    Chen, S.
    LeBoeuf, N.
    Reynolds, K.
    Yu, K.
    Tsao, H.
    Demehri, S.
    Gusev, A.
    Kwatra, S. G.
    Semenov, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S36 - S36
  • [49] Immune dysregulation in cancer patients developing immune-related adverse events
    Shaheen Khan
    Saad A. Khan
    Xin Luo
    Farjana J. Fattah
    Jessica Saltarski
    Yvonne Gloria-McCutchen
    Rong Lu
    Yang Xie
    Quan Li
    Edward Wakeland
    David E. Gerber
    British Journal of Cancer, 2019, 120 : 63 - 68
  • [50] Immune dysregulation in cancer patients developing immune-related adverse events
    Khan, Shaheen
    Khan, Saad A.
    Luo, Xin
    Fattah, Farjana J.
    Saltarski, Jessica
    Gloria-McCutchen, Yvonne
    Lu, Rong
    Xie, Yang
    Li, Quan
    Wakeland, Edward
    Gerber, David E.
    BRITISH JOURNAL OF CANCER, 2019, 120 (01) : 63 - 68
12345